Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): Acute and 30-day results

Journal of Cardiovascular Surgery

Volumn 48, Issue 6, 2007, Pages 719-726

  Zeller, Thomas ^a   Saratzis, N ^b   Scheinert, D ^c   Minar, E ^d   Beregi, J P ^e   Schillinger, M ^d   Hausegger, H A ^f   Amor, M ^g   Quaretti, P ^h   Moratto, R ⁱ   Dorange, C ^k   Boone, E ^k   Krankenberg, H ^j  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e Duplex and Angiographic Core Lab   (France)

^f GENERAL HOSPITAL KLAGENFURT   (Austria)

^g Policlinique Louis Pasteur   (France)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ Nuovo Ospedale S Agostino   (Italy)

^j Abbott Vascular International BVBA   (Belgium)

^k UNIVERSITY HEART CENTER HAMBURG   (Germany)

more..

Author keywords

Arterial occlusive diseases; Femoral artery; Nitinol; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; NITINOL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HUMAN; IMPLANT REGISTRY; LEG AMPUTATION; LEG REVASCULARIZATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; RESTENOSIS; STENT; SUPERFICIAL FEMORAL ARTERY; VASCULAR DISEASE; VASCULAR PATENCY;

EID: 37248998924     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999;19;538-45.
2. Diehm C, Schuster A, Allenberg JA, Darius H, Haberl R, Lange S et al. High prevalence of peripheral arterial disease and co-morbidity in 6 880 primary care patients: a cross-sectional study. Atherosclerosis 2004;172:95-105.
3. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989;170:921-40.
4. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83:I 70-I 80.
5. Murray JG, Apthorp LA, Wilkins RA. Long segment (>10 cm) femoropopliteal angioplasty: improved technical success and longterm patency. Radiology 1995;195:158-62.
6. Krepel VM, van Andel GJ, van Erp WF, Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology 1985;156:325-8.
7. Clark TW, Groffsky JL, Soulen MC. Predictors of long term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 2001;12:923-33.
8. Gordon IL, Conroy RM, Arefi M, Tobis JM, Stemmer EA, Wilson SE. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 2001;136:221-8.
9. Henry M, Amor M, Ethevenot G, Allaoui M, Tricoche O, Porte JM et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995;197:167-74.
10. Bergeron P, Pinot JJ, Poyen V, Benichou H, Kharoyan P, Rudondy P et al. Long-term results with the Palmaz stent in the superficial femoral artery. J Endovasc Surg 1995;2:161-7.
11. Chatelard P, Guibourt C. Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg 1996;37:67-72.
12. Damaraju S, Cuasay L, Le D, Strickman N, Krajcer Z. Predictors of primary patency failure in Wallstent self-expanding endovascular prostheses for iliofemoral occlusive disease. Tex Heart Inst J 1997;24:173-8.
13. Martin EC, Katzen BT, Benenati JF, Diethrich EB, Dorros G, Graor RA et al. Multicenter trial of the Wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 1995;6:843-9.
14. Hayerizade R, Zeller T, Krankenberg H, Scheinert D, Rastan A, Bräunlich S et al. Long-term outcome of superficial femoral artery stenting using nitinol stents compared with stainless steel stents. A multicenter study. Am J Cardiol 2003;92 (Suppl):S157L.
15. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score adjusted analysis. Radiology 2004;232:516-21.
16. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354;1879-88.
17. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13: 701-10.
18. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1-S75; J Vasc Surg. 2007;45:S5-S67.
19. Shouse HB, Nikanorov A, LaFlash D. Biomechanical forces in the femoropopliteal arterial segment. Endovascular Today 2005;4:60-6.
20. Strecker EP, Hagen B, Liermann D Schneider B, Wolf HR, Wambsganss J. Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents. Cardiovasc Intervent Radiol 1993;16:158-64.
21. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31.
22. Zdanowsky Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne E et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999;18:251-5.
23. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-5.
24. Mewissen MW. Nitinol stents in the femoropopliteal arterial segment. Endovascular Today 2005;4:29-34.
25. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-8.
26. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.